SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-003362
Filing Date
2021-02-19
Accepted
2021-02-19 08:52:08
Documents
2
Period of Report
2021-02-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20210218_8k.htm 8-K 89657
2 EXHIBIT 23.1 ex_227758.htm EX-23.1 2953
  Complete submission text file 0001437749-21-003362.txt   93686
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 21652144
SIC: 2834 Pharmaceutical Preparations